Chronic cough: unmet needs, management and expert insights
Welcome to this EBAP-accredited webinar on chronic cough, which took place live on the 21st of June 2023.
Please answer these three pre-webinar questions to assess your background knowledge of chronic cough - don't forget to submit your answers via the link at the end of the questions to proceed
You will be able to view the answers to these questions in the evaluation form after watching the full webinar.
|Chronic cough: unmet needs, management and expert insights
Date and time: Wednesday 21 June 2023, 14:00 UTC
|14:00||Welcome address||Professor Kian Fan Chung|
|14:05||Topic 1: Cough hypersensitivity, treatment options and unmet needs of chronic cough||Professor Kian Fan Chung|
|14:20||Topic 2: Pathways for early diagnosis of chronic cough||Associate Professor Marta Maria Dąbrowska|
|14:35||Topic 3: The physical, psychological, and social impact of chronic cough||Professor Alyn Morice|
|14:55||Closing remarks||Professor Kian Fan Chung|
After watching this webinar you should be able to:
- Identify the physical, psychological and social factors that impact the management of chronic cough
- Describe the challenges associated with the diagnostic pathways of chronic cough
- State the ERS guideline recommendations for the treatment of chronic cough
Professor Kian Fan Chung
Professor Kian Fan Chung MD, DSc is Professor of Respiratory Medicine and Head of Experimental Studies Medicine at the National Heart and Lung Institute, Imperial College London. He is a consultant respiratory physician at Royal Brompton and Harefield Hospitals, London. Professor Chung’s current interests are focused on the role of airway smooth muscle and the effects of oxidant stress on muscle function; on the energetics of airway smooth muscle function; and on the mechanisms underlying corticosteroid resistance. He has an interest in chronic cough, the cough hypersensitivity syndrome and in developing new treatments for this condition. Professor Chung is a senior investigator at the UK National Institute for Health Research and serves on the editorial boards of Respirology, Lancet Respiratory Medicine and the European Journal of Pharmacology.
Disclosures: Professor Chung reports receiving research grants through Imperial College from GSK on asthma and from Merck on chronic cough. He has participated in advisory board meetings for GSK, AstraZeneca, Novartis, Roche, Merck, Rickett-Beckinson, Nocion and Shionogi on asthma, chronic obstructive pulmonary disease (COPD) and chronic cough. He has undertaken speaking engagements for Sanofi, Novartis, AstraZeneca and Merck. He is on the Scientific Advisory Board of the Clean Breathing Institute supported by Haleon. He obtained educational support from Merck to his institution for the 12th London International Cough Symposium held in July 2022.
Associate Professor Marta Maria Dąbrowska
Professor Marta Maria Dąbrowska MD, PhD, DSc is Associate Professor at the Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland. Her research interests include the management of adults with chronic cough, chest imaging and bronchoscopy. Professor Dabrowska is a leader of the cough clinic in the Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, and is the Polish National Lead in NEUROCOUGH, European Respiratory Society (ERS) Clinical Research Collaboration.
Disclosures: Professor Dąbrowska has received consulting fees from MSD.
Professor Alyn Morice
Professor Alyn Hugh Morice MD, FRCP, FBPhS was appointed Foundation Chair, and Professor and Head of Respiratory Research Group, Hull York Medical School, University of Hull, UK in 1998. He has pioneered investigation into the epidemiology, diagnosis and therapeutics of cough, culminating in the production of national and ERS cough guidelines (ERJ 2020). His research on the neuronal mechanisms has improved our understanding leading to the concept of cough hypersensitivity, which has been translated by randomised controlled trials into therapeutic advances (opiates and P2X3 antagonists).
Disclosures: Professor Morice has received consulting fees from Bayer, Bellus, Merck, NeRRi and Shionogi; lecture fees from Boehringer Ingelheim, Merck and Chiesi; and grant support from Bayer, Bellus, Merck, Nocion, Philips, NeRRi and Shionogi.
Requirements for successful completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form. Upon completion, certificates will be issued within 5 working days.
Following evaluation by the European Board for Accreditation in Pneumology (EBAP), the above-mentioned CME activity has been accredited by EBAP for 1 CME credit.
This content has been developed independently of the sponsor, Merck Sharp & Dohme, which has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.